STOCK TITAN

Vericel (VCEL) director gains RSUs, options and more common shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Vericel Corp director Alan L. Rubino increased his equity-based holdings through routine compensation awards and vesting. He acquired 3,200 shares of common stock via the vesting and conversion of previously granted Restricted Stock Units (RSUs), bringing his direct common stock holdings to 64,194 shares.

He also received a new grant of 3,200 RSUs, each representing a contingent right to one Vericel common share, which vest 100% on the earlier of April 29, 2027, or the first Annual Meeting of Stockholders following April 29, 2026. In addition, he was granted stock options for 8,000 shares at an exercise price of $33.43 per share, vesting in equal monthly increments over one year and expiring on April 29, 2036. These transactions reflect equity compensation and do not include any open-market purchases or sales.

Positive

  • None.

Negative

  • None.
Insider Rubino Alan L
Role null
Type Security Shares Price Value
Exercise Restricted Stock Unit 3,200 $0.00 --
Grant/Award Stock Option (Right to Buy) 8,000 $0.00 --
Grant/Award Restricted Stock Unit 3,200 $0.00 --
Exercise Common Stock 3,200 $0.00 --
Holdings After Transaction: Restricted Stock Unit — 0 shares (Direct, null); Stock Option (Right to Buy) — 8,000 shares (Direct, null); Common Stock — 64,194 shares (Direct, null)
Footnotes (1)
  1. The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (RSUs) granted to the Reporting Person on April 30, 2025. Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation. These RSUs vest 100% on the earlier of April 30, 2026, or the date of the first Annual Meeting of Stockholders following April 30, 2025. No expiration date for this type of award. The option vests over a 1-year period, in equal monthly increments, contingent upon continued service to the Company. These RSUs vest 100% on the earlier of April 29, 2027, or the date of the first Annual Meeting of Stockholders following April 29, 2026.
Common shares acquired via RSU vesting 3,200 shares Vesting and conversion of Restricted Stock Units on April 29, 2026
Common shares held after transactions 64,194 shares Direct Vericel common stock holdings following Form 4 transactions
New RSU grant size 3,200 RSUs RSUs vest 100% on earlier of April 29, 2027 or specified Annual Meeting
New stock option grant 8,000 options Right to buy Vericel common stock, vesting monthly over one year
Stock option exercise price $33.43 per share Exercise price for 8,000-share stock option grant expiring April 29, 2036
Derivative exercises in filing 3,200 shares Exercise or conversion of derivative security as summarized in transaction data
Restricted Stock Unit financial
"The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (RSUs)..."
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
contingent right financial
"Each RSU represents a contingent right to receive one share of common stock..."
Stock Option (Right to Buy) financial
"Stock Option (Right to Buy) ... underlying security title: Common Stock"
Annual Meeting of Stockholders financial
"These RSUs vest 100% on the earlier of April 29, 2027, or the date of the first Annual Meeting of Stockholders following April 29, 2026."
exercise price financial
"conversion_or_exercise_price: 33.4300 for the stock option grant"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Rubino Alan L

(Last)(First)(Middle)
C/O VERICEL CORPORATION
64 SIDNEY STREET

(Street)
CAMBRIDGE MASSACHUSETTS 02139

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Vericel Corp [ VCEL ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
04/29/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock04/29/2026M3,200A(1)64,194D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Unit(2)04/29/2026M3,200 (3) (4)Common Stock3,200$00D
Stock Option (Right to Buy)$33.4304/29/2026A8,000 (5)04/29/2036Common Stock8,000$08,000D
Restricted Stock Unit(2)04/29/2026A3,200 (6) (4)Common Stock3,200$03,200D
Explanation of Responses:
1. The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (RSUs) granted to the Reporting Person on April 30, 2025.
2. Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation.
3. These RSUs vest 100% on the earlier of April 30, 2026, or the date of the first Annual Meeting of Stockholders following April 30, 2025.
4. No expiration date for this type of award.
5. The option vests over a 1-year period, in equal monthly increments, contingent upon continued service to the Company.
6. These RSUs vest 100% on the earlier of April 29, 2027, or the date of the first Annual Meeting of Stockholders following April 29, 2026.
/s/ Sean Flynn, as Attorney-in-Fact for Alan Rubino05/01/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transactions did Vericel (VCEL) director Alan Rubino report?

Alan Rubino reported equity compensation activity, including RSU vesting into common stock, a new RSU grant, and a new stock option grant. These moves increased his equity-based stake without any open-market share purchases or sales disclosed in this filing.

How many Vericel (VCEL) common shares does Alan Rubino hold after these transactions?

After these transactions, Alan Rubino directly holds 64,194 shares of Vericel common stock. This total reflects the addition of 3,200 shares acquired through the vesting and conversion of previously granted Restricted Stock Units reported in this Form 4.

What Restricted Stock Unit (RSU) awards did Vericel (VCEL) grant to Alan Rubino?

Vericel granted Alan Rubino 3,200 new Restricted Stock Units. Each RSU represents a contingent right to receive one share of Vericel common stock, vesting 100% on the earlier of April 29, 2027, or the first Annual Meeting of Stockholders following April 29, 2026.

What are the terms of Alan Rubino’s new Vericel (VCEL) stock option grant?

Rubino received stock options covering 8,000 Vericel common shares at an exercise price of $33.43 per share. These options vest over one year in equal monthly increments, contingent on continued service, and expire on April 29, 2036 if not exercised.

Did Alan Rubino buy or sell Vericel (VCEL) shares on the open market in this filing?

This filing does not report any open-market purchases or sales by Alan Rubino. The reported transactions are equity compensation-related: RSU vesting into common stock, a new RSU grant, and a new stock option grant, all categorized as acquisition-type events.

How were the 3,200 Vericel (VCEL) shares acquired by Alan Rubino generated?

The 3,200 Vericel shares were acquired through the vesting and conversion of Restricted Stock Units. Footnotes explain the RSUs were previously granted and each RSU converts into one share of common stock upon vesting, rather than being purchased in the market.